Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis – Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry

Bente Glintborg, Tina Marie Kringelbach, E. Høgdall, Inge Juul Sørensen, Dorte Vendelbo Jensen, A. G. Loft, O. Hendricks, I. M. J. Hansen, A. Linauskas, S. Kristensen, H. Lindegaard, Henrik Nordin, N. Bolstad, D. Warren, D. Warren, J. Gehin, G. L. Goll, Kathrine Lederballe Grøn, Grith P Eng, Christian EnevoldClaus Henrik Nielsen, Julia Sidenius Johansen, Merete Lund Hetland

Original languageEnglish
Article number1997
JournalArthritis & Rheumatology
Volume68
Issue numberS10
ISSN1537-2960
Publication statusPublished - 2016

Cite this